









市场行情
/
股票
/
nasdaq-cdxs
/

Codexis Inc

CDXS

1.703USD

+0.043+2.59%

交易中（美东）报价延迟15分钟

153.75M总市值

亏损市盈率 TTM



Codexis Inc

1.703

+0.043+2.59%

概览公司财务分析

概览

公司

财务

分析

关于 Codexis Inc 公司

Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Codexis Inc简介



公司代码CDXS

公司名称Codexis Inc

上市日期Apr 22, 2010

CEOMoore (Alison)

员工数量188

证券类型Ordinary Share

年结日Apr 22

公司地址200 Penobscot Dr

城市REDWOOD CITY

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编94063

电话16504218100

网址https://www.codexis.com/

公司代码CDXS

上市日期Apr 22, 2010

CEOMoore (Alison)

Codexis Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. David V. Smith

Lead Independent Director

194.28K

+26.74%

Dr. Alison Moore, Ph.D.

President, Chief Executive Officer, Director

177.46K

+91.93%

Mr. Kevin Norrett

Chief Operating Officer

160.27K

+10.73%

Mr. Dennis P. Wolf

Independent Director

138.95K

-6.05%

Dr. Rahul Singhvi

Independent Director

132.05K

+45.00%

Dr. Esther Martinborough, Ph.D.

Independent Director

129.04K

+46.54%

Ms. Cynthia Collins

Independent Director

112.16K

+57.58%

Dr. Raymond De Vre, Ph.D.

Independent Director

87.42K

-1.59%

Mr. Christos Richards

Independent Director

85.13K

+92.83%

Ms. Georgia L. Erbez

Chief Financial Officer

70.64K

-8.12%

名称

名称/职务

职务

持股

持股变动

Mr. David V. Smith

Lead Independent Director

194.28K

+26.74%

Dr. Alison Moore, Ph.D.

President, Chief Executive Officer, Director

177.46K

+91.93%

Mr. Kevin Norrett

Chief Operating Officer

160.27K

+10.73%

Mr. Dennis P. Wolf

Independent Director

138.95K

-6.05%

Dr. Rahul Singhvi

Independent Director

132.05K

+45.00%

Dr. Esther Martinborough, Ph.D.

Independent Director

129.04K

+46.54%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

由于公司未披露，未能获取相关数据

地区USD

名称

营收

占比

APAC

6.58M

42.93%

America

6.35M

41.44%

EMEA

2.40M

15.63%

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 11月16日周日

持股股东

股东类型

持股股东

占比

Opaleye Management Inc.

9.95%

BlackRock Institutional Trust Company, N.A.

6.50%

The Vanguard Group, Inc.

5.17%

abrdn Inc.

4.53%

Millennium Management LLC

4.50%

其他

69.34%

持股股东

占比

Opaleye Management Inc.

9.95%

BlackRock Institutional Trust Company, N.A.

6.50%

The Vanguard Group, Inc.

5.17%

abrdn Inc.

4.53%

Millennium Management LLC

4.50%

其他

69.34%

股东类型

持股股东

占比

Investment Advisor

27.10%

Hedge Fund

21.96%

Investment Advisor/Hedge Fund

19.88%

Individual Investor

2.88%

Research Firm

1.22%

Pension Fund

0.20%

Bank and Trust

0.18%

Insurance Company

0.03%

Venture Capital

0.02%

其他

26.52%

机构持股



更新时间: 12月8日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q4

259

63.79M

84.44%

-3.19M

2025Q3

270

67.24M

85.39%

-6.33M

2025Q2

272

73.50M

96.12%

+3.66M

2025Q1

304

67.35M

93.04%

-9.72M

2024Q4

323

66.35M

93.32%

+1.38M

2024Q3

331

65.10M

96.64%

+10.35M

2024Q2

345

54.66M

101.93%

-1.25M

2024Q1

358

56.38M

110.38%

-21.50M

2023Q4

374

58.04M

110.76%

+374.07K

2023Q3

379

57.61M

110.71%

-5.54M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Opaleye Management Inc.

12.61M

13.97%

+10.00K

+0.08%

Jul 30, 2025

BlackRock Institutional Trust Company, N.A.

5.85M

6.48%

-376.85K

-6.05%

Jun 30, 2025

The Vanguard Group, Inc.

4.59M

5.08%

-135.73K

-2.87%

Jun 30, 2025

abrdn Inc.

4.20M

4.65%

+3.59M

+592.89%

Jun 30, 2025

Nantahala Capital Management, LLC

4.03M

4.47%

+1.20M

+42.39%

Jun 30, 2025

Telemark Asset Management, LLC

4.00M

4.43%

+1.00M

+33.33%

Jun 30, 2025

Columbia Threadneedle Investments (US)

2.55M

2.83%

+16.10K

+0.64%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.98M

2.19%

+52.59K

+2.73%

Jun 30, 2025

Pier Capital, LLC

1.92M

2.12%

+245.96K

+14.73%

Jun 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

Invesco NASDAQ Future Gen 200 ETF

0.47%

iShares Micro-Cap ETF

0.04%

Invesco Nasdaq Biotechnology ETF

0.02%

Fidelity Enhanced Small Cap ETF

0.02%

iShares Biotechnology ETF

0.02%

ProShares Ultra Nasdaq Biotechnology

0.02%

Global X Russell 2000 ETF

0.01%

Invesco RAFI US 1500 Small-Mid ETF

0.01%

Proshares Ultra Russell 2000

0.01%

iShares Russell 2000 Growth ETF

0.01%

Invesco NASDAQ Future Gen 200 ETF

占比0.47%

iShares Micro-Cap ETF

占比0.04%

Invesco Nasdaq Biotechnology ETF

占比0.02%

Fidelity Enhanced Small Cap ETF

占比0.02%

iShares Biotechnology ETF

占比0.02%

ProShares Ultra Nasdaq Biotechnology

占比0.02%

Global X Russell 2000 ETF

占比0.01%

Invesco RAFI US 1500 Small-Mid ETF

占比0.01%

Proshares Ultra Russell 2000

占比0.01%

iShares Russell 2000 Growth ETF

占比0.01%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Codexis Inc的前五大股东是谁？



Codexis Inc 的前五大股东如下：
Opaleye Management Inc.持有股份：12.61M，占总股份比例：13.97%。
BlackRock Institutional Trust Company, N.A.持有股份：5.85M，占总股份比例：6.48%。
The Vanguard Group, Inc.持有股份：4.59M，占总股份比例：5.08%。
abrdn Inc.持有股份：4.20M，占总股份比例：4.65%。
Nantahala Capital Management, LLC持有股份：4.03M，占总股份比例：4.47%。